• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过外显子包含在诱导多能干细胞衍生的骨骼肌细胞中缓解庞贝病中的酸性α-葡萄糖苷酶缺乏症。

GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells.

作者信息

van der Wal Erik, Bergsma Atze J, van Gestel Tom J M, In 't Groen Stijn L M, Zaehres Holm, Araúzo-Bravo Marcos J, Schöler Hans R, van der Ploeg Ans T, Pijnappel W W M Pim

机构信息

Molecular Stem Cell Biology, Department of Clinical Genetics, Erasmus Medical Center, 3015 CN Rotterdam, the Netherlands; Department of Pediatrics, Erasmus Medical Center, 3015 CN Rotterdam, the Netherlands; Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, 3015 GE Rotterdam, the Netherlands.

Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany.

出版信息

Mol Ther Nucleic Acids. 2017 Jun 16;7:101-115. doi: 10.1016/j.omtn.2017.03.002. Epub 2017 Mar 14.

DOI:10.1016/j.omtn.2017.03.002
PMID:28624186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5415960/
Abstract

Pompe disease is a metabolic myopathy caused by deficiency of the acid α-glucosidase (GAA) enzyme and results in progressive wasting of skeletal muscle cells. The c.-32-13T>G (IVS1) GAA variant promotes exon 2 skipping during pre-mRNA splicing and is the most common variant for the childhood/adult disease form. We previously identified antisense oligonucleotides (AONs) that promoted GAA exon 2 inclusion in patient-derived fibroblasts. It was unknown how these AONs would affect GAA splicing in skeletal muscle cells. To test this, we expanded induced pluripotent stem cell (iPSC)-derived myogenic progenitors and differentiated these to multinucleated myotubes. AONs restored splicing in myotubes to a similar extent as in fibroblasts, suggesting that they act by modulating the action of shared splicing regulators. AONs targeted the putative polypyrimidine tract of a cryptic splice acceptor site that was part of a pseudo exon in GAA intron 1. Blocking of the cryptic splice donor of the pseudo exon with AONs likewise promoted GAA exon 2 inclusion. The simultaneous blocking of the cryptic acceptor and cryptic donor sites restored the majority of canonical splicing and alleviated GAA enzyme deficiency. These results highlight the relevance of cryptic splicing in human disease and its potential as therapeutic target for splicing modulation using AONs.

摘要

庞贝病是一种由酸性α-葡萄糖苷酶(GAA)缺乏引起的代谢性肌病,会导致骨骼肌细胞进行性萎缩。c.-32-13T>G(IVS1)GAA变体在mRNA前体剪接过程中促进外显子2跳跃,是儿童/成人疾病形式中最常见的变体。我们之前鉴定出了能促进GAA外显子2包含在患者来源成纤维细胞中的反义寡核苷酸(AON)。这些AON如何影响骨骼肌细胞中的GAA剪接尚不清楚。为了对此进行测试,我们扩增了诱导多能干细胞(iPSC)来源的肌源性祖细胞,并将其分化为多核肌管。AON在肌管中恢复剪接的程度与在成纤维细胞中相似,这表明它们通过调节共享剪接调节因子的作用来发挥作用。AON靶向GAA内含子1中一个假外显子的隐蔽剪接受体位点的假定多嘧啶序列。用AON阻断假外显子的隐蔽剪接供体同样促进了GAA外显子2的包含。同时阻断隐蔽受体和隐蔽供体位点可恢复大部分正常剪接并减轻GAA酶缺乏。这些结果突出了隐蔽剪接在人类疾病中的相关性及其作为使用AON进行剪接调节治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/9326603131ac/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/7dfb1e75e112/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/47664ea3be70/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/6e8c5f10fe17/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/3ca63c93bfbf/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/cb4a46e7124b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/9326603131ac/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/7dfb1e75e112/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/47664ea3be70/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/6e8c5f10fe17/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/3ca63c93bfbf/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/cb4a46e7124b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe6/5415960/9326603131ac/gr6.jpg

相似文献

1
GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells.通过外显子包含在诱导多能干细胞衍生的骨骼肌细胞中缓解庞贝病中的酸性α-葡萄糖苷酶缺乏症。
Mol Ther Nucleic Acids. 2017 Jun 16;7:101-115. doi: 10.1016/j.omtn.2017.03.002. Epub 2017 Mar 14.
2
Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease.反义寡核苷酸促进外显子包含并纠正庞贝病中常见的c.-32-13T>G GAA剪接变体。
Mol Ther Nucleic Acids. 2017 Jun 16;7:90-100. doi: 10.1016/j.omtn.2017.03.001. Epub 2017 Mar 14.
3
Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology.评估与 GAA 外显子 2 中庞贝病相关的 28 个核苷酸变异对 pre-mRNA 剪接过程的功能影响及其使用反义技术的恢复情况。
Hum Mutat. 2019 Nov;40(11):2121-2130. doi: 10.1002/humu.23867. Epub 2019 Jul 29.
4
Glycogen Reduction in Myotubes of Late-Onset Pompe Disease Patients Using Antisense Technology.使用反义技术减少晚期庞贝病患者肌管中的糖原。
Mol Ther. 2017 Sep 6;25(9):2117-2128. doi: 10.1016/j.ymthe.2017.05.019. Epub 2017 Jun 16.
5
Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease.拼接调节反义寡核苷酸可恢复晚期庞贝病患者来源细胞中的一些酸性-α-葡萄糖苷酶活性。
Sci Rep. 2020 Apr 21;10(1):6702. doi: 10.1038/s41598-020-63461-2.
6
Developing Therapeutic Splice-Correcting Antisense Oligomers for Adult-Onset Pompe Disease with c.-32-13T>G Mutation.开发用于治疗 c.-32-13T>G 突变的成年发病庞贝病的治疗性剪接校正反义寡核苷酸。
Methods Mol Biol. 2023;2587:239-251. doi: 10.1007/978-1-0716-2772-3_14.
7
Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.新型 GAA 序列变异 c.1211 A>G 降低婴儿和成人发病庞贝病的酶活性,但不降低蛋白表达。
Gene. 2014 Mar 1;537(1):41-5. doi: 10.1016/j.gene.2013.12.033. Epub 2013 Dec 30.
8
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.抗肌萎缩蛋白基因中反义寡核苷酸诱导外显子跳跃的靶点选择
J Gene Med. 2003 Jun;5(6):518-27. doi: 10.1002/jgm.361.
9
Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts.甲磺酸去铁胺可改善晚发性帕金森病患者成纤维细胞中常见的c.-32-13T>G等位基因的剪接和GAA活性。
Mol Ther Methods Clin Dev. 2020 Nov 20;20:227-236. doi: 10.1016/j.omtm.2020.11.011. eCollection 2021 Mar 12.
10
Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents.GAA 基因常见 c.-32-13T>G 突变的功能特征:潜在治疗药物的鉴定。
Nucleic Acids Res. 2014 Jan;42(2):1291-302. doi: 10.1093/nar/gkt987. Epub 2013 Oct 22.

引用本文的文献

1
Elucidating the role of human skeletal muscles in the pathogenesis of enterovirus D68 infection.阐明人类骨骼肌在肠道病毒D68感染发病机制中的作用。
Life Sci Alliance. 2025 Sep 5;8(11). doi: 10.26508/lsa.202503372. Print 2025 Nov.
2
Functional Analysis of Complex Structural and Splice-Altering Variants in the Gene Towards the Personalized Antisense-Based Therapy for Mucopolysaccharidosis Type VI Patients.针对黏多糖贮积症VI型患者基于反义技术的个性化治疗,对该基因中复杂结构和剪接改变变体的功能分析
Hum Mutat. 2025 Jan 10;2025:2250030. doi: 10.1155/humu/2250030. eCollection 2025.
3
Case Report: Incidental late-onset Pompe disease diagnosis in a man with no clinical and instrumental evidence of neuromuscular dysfunction.

本文引用的文献

1
Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease.反义寡核苷酸促进外显子包含并纠正庞贝病中常见的c.-32-13T>G GAA剪接变体。
Mol Ther Nucleic Acids. 2017 Jun 16;7:90-100. doi: 10.1016/j.omtn.2017.03.001. Epub 2017 Mar 14.
2
Metabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle Pathology.庞贝病诱导多能干细胞衍生心肌细胞的代谢组学分析揭示氧化应激与心脏和骨骼肌病变有关。
Stem Cells Transl Med. 2017 Jan;6(1):31-39. doi: 10.5966/sctm.2015-0409. Epub 2016 Aug 18.
3
病例报告:一名男性患者偶然被诊断为迟发性庞贝病,其无神经肌肉功能障碍的临床及影像学证据。
Front Genet. 2025 Jun 23;16:1574381. doi: 10.3389/fgene.2025.1574381. eCollection 2025.
4
Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease.在庞贝病小鼠模型中,靶向糖原合酶1的反义寡核苷酸对骨骼肌的影响。
Clin Transl Med. 2025 Apr;15(4):e70314. doi: 10.1002/ctm2.70314.
5
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe disease.通过肽偶联吗啉代寡核苷酸进行剪接校正作为晚发型庞贝病的一种新疗法。
Mol Ther Nucleic Acids. 2025 Mar 27;36(2):102524. doi: 10.1016/j.omtn.2025.102524. eCollection 2025 Jun 10.
6
Management of Pompe disease alongside and beyond ERT: a narrative review.庞贝病在酶替代疗法及其他方面的管理:一篇叙述性综述
Acta Myol. 2025 Mar;44(1):11-22. doi: 10.36185/2532-1900-1106.
7
A knock down strategy for rapid, generic, and versatile modelling of muscular dystrophies in 3D-tissue-engineered-skeletal muscle.一种敲除策略,可快速、通用且灵活地对 3D 组织工程化骨骼肌中的肌肉疾病进行建模。
Skelet Muscle. 2024 Feb 22;14(1):3. doi: 10.1186/s13395-024-00335-5.
8
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.剪接调节反义寡核苷酸作为遗传性代谢疾病的治疗方法。
BioDrugs. 2024 Mar;38(2):177-203. doi: 10.1007/s40259-024-00644-7. Epub 2024 Jan 22.
9
Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy.新生儿溶酶体贮积症筛查中的光明与阴影:意大利东北部八年经验
Int J Neonatal Screen. 2023 Dec 25;10(1):3. doi: 10.3390/ijns10010003.
10
Variant Classification for Pompe disease; ACMG/AMP specifications from the ClinGen Lysosomal Diseases Variant Curation Expert Panel.庞贝病变异分类;ClinGen 溶酶体疾病变异临床解读专家小组的 ACMG/AMP 规范。
Mol Genet Metab. 2023 Sep-Oct;140(1-2):107715. doi: 10.1016/j.ymgme.2023.107715. Epub 2023 Oct 26.
From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides.
从庞贝病中隐秘的前体mRNA剪接走向经典剪接:反义寡核苷酸开发的流程
Mol Ther Nucleic Acids. 2016 Sep 13;5(9):e361. doi: 10.1038/mtna.2016.75.
4
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.全身性肽介导的寡核苷酸疗法可提高脊髓性肌萎缩症的长期生存率。
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10962-7. doi: 10.1073/pnas.1605731113. Epub 2016 Sep 12.
5
TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle.TFEB 过表达促进庞贝病 iPSC 衍生骨骼肌中的糖原清除。
Mol Ther Methods Clin Dev. 2016 Aug 10;3:16054. doi: 10.1038/mtm.2016.54. eCollection 2016.
6
Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis.晚期庞贝病患者接受阿糖苷酶 α 治疗后的生存和长期结局:系统评价和荟萃分析。
J Neurol. 2017 Apr;264(4):621-630. doi: 10.1007/s00415-016-8219-8. Epub 2016 Jul 2.
7
Peptides for nucleic acid delivery.用于核酸递送的肽。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):172-182. doi: 10.1016/j.addr.2016.06.008. Epub 2016 Jun 25.
8
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy.利益相关者合作克服孤儿药开发中的挑战:以杜氏肌营养不良症为例。
Lancet Neurol. 2016 Jul;15(8):882-890. doi: 10.1016/S1474-4422(16)30035-7.
9
Splice-switching antisense oligonucleotides as therapeutic drugs.作为治疗药物的剪接转换反义寡核苷酸
Nucleic Acids Res. 2016 Aug 19;44(14):6549-63. doi: 10.1093/nar/gkw533. Epub 2016 Jun 10.
10
Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.基于人诱导多能干细胞模型的杜氏肌营养不良症患者特异性成肌细胞的表型一致但存在差异。
Cell Rep. 2016 Jun 7;15(10):2301-2312. doi: 10.1016/j.celrep.2016.05.016. Epub 2016 May 26.